ATP6V0C-HIF-1α reciprocal activation drives acute lung injury.

Summary

Using alveolar epithelial knockouts and overexpression systems, the study demonstrates a reciprocal ATP6V0C–HIF-1α loop that amplifies epithelial apoptosis and inflammation in ALI. BALF ATP6V0C was elevated and correlated with ARDS severity, nominating the axis as a biomarker and therapeutic target.

Key Findings

• ATP6V0C is upregulated in murine ALI lungs and in BALF (but not serum) from severe ARDS patients, correlating with severity.
• Alveolar epithelial-specific ATP6V0C deletion attenuated LPS-induced ALI without increasing susceptibility to bacterial infection.
• ATP6V0C physically interacts with HIF-1α; overexpression worsened ALI in Hif1a fl/fl mice but not in Hif1a AT2-KO mice.
• HIF-1α transcriptionally regulates ATP6V0C, forming a detrimental positive feedback loop that enhances apoptosis and inflammation.

Clinical Implications

While not immediately practice-changing, BALF ATP6V0C could aid risk stratification, and pharmacologic disruption of the ATP6V0C–HIF-1α loop may mitigate epithelial injury in ARDS.

Limitations

• Primarily LPS-induced ALI models; generalizability to diverse ARDS etiologies is uncertain.
• Clinical data are correlative with unspecified sample size; no therapeutic inhibitor tested in vivo.

Future Directions

Quantify BALF ATP6V0C in larger ARDS cohorts; develop/selective inhibitors or RNA-based approaches to disrupt the ATP6V0C–HIF-1α loop and test efficacy and safety in translational models.